Ascendis Pharma (spons. ADRs) Aktie
186,00
EUR
+5,00
EUR
+2,76
%
223,36
USD
+7,01
USD
+3,24
%
Werbung
Ascendis Pharma (spons. ADRs) Aktie Analyse
| 24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
| 26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
| 26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung